150 related articles for article (PubMed ID: 36436682)
21. The circular RNA circPTK2 inhibits EMT in hepatocellular carcinoma by acting as a ceRNA and sponging miR-92a to upregulate E-cadherin.
Gong TT; Sun FZ; -Y Chen J; Liu JF; Yan Y; Li D; Zhou B; Shan H
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9333-9342. PubMed ID: 33015774
[TBL] [Abstract][Full Text] [Related]
22. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma.
Pan Z; Lin J; Wu D; He X; Wang W; Hu X; Zhang L; Wang M
Aging (Albany NY); 2019 Dec; 11(24):11937-11954. PubMed ID: 31881015
[TBL] [Abstract][Full Text] [Related]
23. Silencing circ‑BIRC6 inhibits the proliferation, invasion, migration and epithelial‑mesenchymal transition of bladder cancer cells by targeting the miR‑495‑3p/XBP1 signaling axis.
Zhou L; Wang B; Zhang Y; Yao K; Liu B
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34542161
[TBL] [Abstract][Full Text] [Related]
24. CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axis.
Shang Z; Ming X; Wu J; Liu W; Xiao Y
Expert Rev Hematol; 2022 Dec; 15(12):1073-1083. PubMed ID: 35980117
[TBL] [Abstract][Full Text] [Related]
25. Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis.
Lin S; Wang L; Shi Z; Zhu A; Zhang G; Hong Z; Cheng C
Bioengineered; 2021 Dec; 12(2):11376-11389. PubMed ID: 34852712
[TBL] [Abstract][Full Text] [Related]
26.
Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G
Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726
[TBL] [Abstract][Full Text] [Related]
27. Novel circRNA_0071196/miRNA‑19b‑3p/CIT axis is associated with proliferation and migration of bladder cancer.
Liu Z; Yang Y; Yang Z; Xia S; Lin D; Xiao B; Xiu Y
Int J Oncol; 2020 Sep; 57(3):767-779. PubMed ID: 32705161
[TBL] [Abstract][Full Text] [Related]
28. Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis.
Yu S; Wang M; Zhang H; Guo X; Qin R
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828307
[TBL] [Abstract][Full Text] [Related]
29. Hsa_circRNA_0088036 acts as a ceRNA to promote bladder cancer progression by sponging miR-140-3p.
Yang J; Qi M; Fei X; Wang X; Wang K
Cell Death Dis; 2022 Apr; 13(4):322. PubMed ID: 35396504
[TBL] [Abstract][Full Text] [Related]
30. circ_100984-miR-432-3p axis regulated c-Jun/YBX-1/β-catenin feedback loop promotes bladder cancer progression.
Tong L; Yang H; Xiong W; Tang G; Zu X; Qi L
Cancer Sci; 2021 Apr; 112(4):1429-1442. PubMed ID: 33314480
[TBL] [Abstract][Full Text] [Related]
31. SNHG16 regulates invasion and migration of bladder cancer through induction of epithelial-to-mesenchymal transition.
Chen W; Jiang T; Mao H; Gao R; Zhang H; He Y; Liu C; Chen Q
Hum Cell; 2020 Jul; 33(3):737-749. PubMed ID: 32207096
[TBL] [Abstract][Full Text] [Related]
32. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
[TBL] [Abstract][Full Text] [Related]
33. CircESRP1 enhances metastasis and epithelial-mesenchymal transition in endometrial cancer via the miR-874-3p/CPEB4 axis.
Shi R; Zhang W; Zhang J; Yu Z; An L; Zhao R; Zhou X; Wang Z; Wei S; Wang H
J Transl Med; 2022 Mar; 20(1):139. PubMed ID: 35317822
[TBL] [Abstract][Full Text] [Related]
34. Circular RNA circPTK2 modulates migration and invasion via miR-136/NFIB signaling on triple-negative breast cancer cells in vitro.
Wang M; Chen D; Zhang H; Luo C
Inflamm Res; 2022 Apr; 71(4):409-421. PubMed ID: 35234989
[TBL] [Abstract][Full Text] [Related]
35. CircPTK2 accelerates tumorigenesis of colorectal cancer by upregulating AKT2 expression via miR-506-3p.
Gong SX; Yang FS; Qiu DD
Kaohsiung J Med Sci; 2022 Nov; 38(11):1060-1069. PubMed ID: 36156852
[TBL] [Abstract][Full Text] [Related]
36. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
[TBL] [Abstract][Full Text] [Related]
37. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.
Shan G; Zhou X; Gu J; Zhou D; Cheng W; Wu H; Wang Y; Tang T; Wang X
Cell Oncol (Dordr); 2021 Feb; 44(1):45-59. PubMed ID: 33423167
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA circMTO1 suppresses bladder cancer metastasis by sponging miR-221 and inhibiting epithelial-to-mesenchymal transition.
Li Y; Wan B; Liu L; Zhou L; Zeng Q
Biochem Biophys Res Commun; 2019 Jan; 508(4):991-996. PubMed ID: 30551873
[TBL] [Abstract][Full Text] [Related]
39. Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway.
Ren L; Jiang M; Xue D; Wang H; Lu Z; Ding L; Xie H; Wang R; Luo W; Xu L; Wang M; Yu S; Cheng S; Xia L; Yu H; Huang P; Xu N; Li G
Int J Biol Sci; 2022; 18(13):5207-5220. PubMed ID: 35982887
[TBL] [Abstract][Full Text] [Related]
40. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence.
Bi J; Liu H; Dong W; Xie W; He Q; Cai Z; Huang J; Lin T
Mol Cancer; 2019 Sep; 18(1):133. PubMed ID: 31481066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
